PubHawk
BMC Med March 2023 PMID 36991487

The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria.

James A Watson, Thomas J Peto, Nicholas J White

Download social card

Mentions

3
Peak: 1 in Mar 2023
across 2 sources since Mar 2023

Extended reach

10,774
potential audience

Total likes

2

Video views

30

Mentions per month

Mar 2023 – Jul 2023

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions reflect a keen interest in the limitations of the CARAMAL study, highlighted by comments like Watson et al.'s critique questioning causal interpretations, and responses from the original authors defending their findings. Words like 'argue' and 'discuss' demonstrate critical engagement, indicating the publication sparks serious analytical debate rather than superficial reactions.

AgreementModerate agreement

Most discussions agree that the study had limitations in assessing the treatment’s effectiveness, with some users supporting the original authors' criticism.

InterestHigh interest

The discussions show a high level of interest, with participants engaging deeply to analyze methodological issues and responses.

EngagementModerate engagement

Comments include references to expert opinions and responses, indicating active and meaningful engagement.

ImpactModerate impact

The dialogue suggests the publication influences ongoing debates about malaria treatment, though it’s not seen as a definitive game-changer.

Abstract in brief

  • The CARAMAL study was an observational study that tracked child mortality related to suspected severe malaria before and after introducing rectal artesunate in Nigeria, Uganda, and the Democratic Republic of the Congo, but it couldn't definitively determine if the treatment is effective.
  • The study's findings led the WHO to pause the widespread use of rectal artesunate, with the abstract claiming it had no proven benefit in saving children's lives.
  • The authors argue that this conclusion is misleading because the study mainly highlights issues with referral systems in these countries and doesn’t provide strong evidence to determine whether rectal artesunate itself improves survival chances.]
Read the full abstract

Top posts

Most liked on X and Bluesky
BMC Medicine
@BMCMedicine · X

Watson et al. from @TropMedOxford discuss the CARAMAL study (https://t.co/1yRmduTamL) arguing that the causal interpretation of the study results is not justified. Read more here: https://t.co/nUPTyxad8Q @lipangalala et al (original authors) respond here https://t.co/7Kc60Kk6EG

Mar 30, 2023 · 2 likes · 9,190 followers View post →
Europe PMC articles
@EuropePMC · X

New from #wellcometrust https://t.co/1qy0fg4pzc The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria.

Apr 4, 2023 · 1,554 followers View post →

All mentions

Europe PMC articles
@EuropePMC · X

New from #wellcometrust https://t.co/1qy0fg4pzc The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria.

Apr 4, 2023 · 1,554 followers View post →
BMC Medicine
@BMCMedicine · X

Watson et al. from @TropMedOxford discuss the CARAMAL study (https://t.co/1yRmduTamL) arguing that the causal interpretation of the study results is not justified. Read more here: https://t.co/nUPTyxad8Q @lipangalala et al (original authors) respond here https://t.co/7Kc60Kk6EG

Mar 30, 2023 · 2 likes · 9,190 followers View post →